nodes	percent_of_prediction	percent_of_DWPC	metapath
Flutamide—CYP1A1—chronic obstructive pulmonary disease	0.279	0.509	CbGaD
Flutamide—CYP1A2—chronic obstructive pulmonary disease	0.269	0.491	CbGaD
Flutamide—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.0492	0.183	CbGbCtD
Flutamide—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.0492	0.183	CbGbCtD
Flutamide—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.0386	0.143	CbGbCtD
Flutamide—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0314	0.117	CbGbCtD
Flutamide—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0212	0.0788	CbGbCtD
Flutamide—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.0207	0.0768	CbGbCtD
Flutamide—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0202	0.0752	CbGbCtD
Flutamide—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.018	0.067	CbGbCtD
Flutamide—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0106	0.0393	CbGbCtD
Flutamide—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00999	0.0371	CbGbCtD
Flutamide—Breast neoplasm—Arformoterol—chronic obstructive pulmonary disease	0.00304	0.034	CcSEcCtD
Flutamide—Breast neoplasm—Formoterol—chronic obstructive pulmonary disease	0.00304	0.034	CcSEcCtD
Flutamide—Traumatic liver injury—Montelukast—chronic obstructive pulmonary disease	0.00241	0.027	CcSEcCtD
Flutamide—Gynaecomastia—Roflumilast—chronic obstructive pulmonary disease	0.00162	0.0181	CcSEcCtD
Flutamide—Herpes zoster—Tiotropium—chronic obstructive pulmonary disease	0.00151	0.0169	CcSEcCtD
Flutamide—Herpes zoster—Formoterol—chronic obstructive pulmonary disease	0.00122	0.0137	CcSEcCtD
Flutamide—Herpes zoster—Arformoterol—chronic obstructive pulmonary disease	0.00122	0.0137	CcSEcCtD
Flutamide—Liver injury—Montelukast—chronic obstructive pulmonary disease	0.00107	0.012	CcSEcCtD
Flutamide—Rectal haemorrhage—Formoterol—chronic obstructive pulmonary disease	0.00102	0.0114	CcSEcCtD
Flutamide—Rectal haemorrhage—Arformoterol—chronic obstructive pulmonary disease	0.00102	0.0114	CcSEcCtD
Flutamide—Cystitis noninfective—Formoterol—chronic obstructive pulmonary disease	0.000896	0.01	CcSEcCtD
Flutamide—Cystitis noninfective—Arformoterol—chronic obstructive pulmonary disease	0.000896	0.01	CcSEcCtD
Flutamide—Cystitis—Formoterol—chronic obstructive pulmonary disease	0.000885	0.00993	CcSEcCtD
Flutamide—Cystitis—Arformoterol—chronic obstructive pulmonary disease	0.000885	0.00993	CcSEcCtD
Flutamide—AHR—bronchus—chronic obstructive pulmonary disease	0.000884	0.0987	CbGeAlD
Flutamide—AHR—smooth muscle tissue—chronic obstructive pulmonary disease	0.000865	0.0966	CbGeAlD
Flutamide—Neoplasm—Formoterol—chronic obstructive pulmonary disease	0.000829	0.0093	CcSEcCtD
Flutamide—Neoplasm—Arformoterol—chronic obstructive pulmonary disease	0.000829	0.0093	CcSEcCtD
Flutamide—Bladder pain—Arformoterol—chronic obstructive pulmonary disease	0.000829	0.0093	CcSEcCtD
Flutamide—Bladder pain—Formoterol—chronic obstructive pulmonary disease	0.000829	0.0093	CcSEcCtD
Flutamide—AHR—trachea—chronic obstructive pulmonary disease	0.000794	0.0886	CbGeAlD
Flutamide—Tension—Roflumilast—chronic obstructive pulmonary disease	0.000775	0.00869	CcSEcCtD
Flutamide—Nervousness—Roflumilast—chronic obstructive pulmonary disease	0.000767	0.0086	CcSEcCtD
Flutamide—Ill-defined disorder—Roflumilast—chronic obstructive pulmonary disease	0.000733	0.00822	CcSEcCtD
Flutamide—Diabetes mellitus—Salbutamol—chronic obstructive pulmonary disease	0.000722	0.0081	CcSEcCtD
Flutamide—Malaise—Roflumilast—chronic obstructive pulmonary disease	0.000712	0.00799	CcSEcCtD
Flutamide—Hyperglycaemia—Aminophylline—chronic obstructive pulmonary disease	0.000682	0.00765	CcSEcCtD
Flutamide—Anxiety—Roflumilast—chronic obstructive pulmonary disease	0.00067	0.00751	CcSEcCtD
Flutamide—Increased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000669	0.0075	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Roflumilast—chronic obstructive pulmonary disease	0.000668	0.00749	CcSEcCtD
Flutamide—Discomfort—Roflumilast—chronic obstructive pulmonary disease	0.000664	0.00745	CcSEcCtD
Flutamide—Hyperglycaemia—Tiotropium—chronic obstructive pulmonary disease	0.000643	0.00721	CcSEcCtD
Flutamide—Haematuria—Aminophylline—chronic obstructive pulmonary disease	0.000643	0.00721	CcSEcCtD
Flutamide—Skin disorder—Roflumilast—chronic obstructive pulmonary disease	0.000626	0.00702	CcSEcCtD
Flutamide—Toxic epidermal necrolysis—Montelukast—chronic obstructive pulmonary disease	0.000587	0.00658	CcSEcCtD
Flutamide—Aspartate aminotransferase increased—Montelukast—chronic obstructive pulmonary disease	0.000587	0.00658	CcSEcCtD
Flutamide—Insomnia—Roflumilast—chronic obstructive pulmonary disease	0.000583	0.00654	CcSEcCtD
Flutamide—AHR—lung—chronic obstructive pulmonary disease	0.000571	0.0637	CbGeAlD
Flutamide—Oedema peripheral—Tiotropium—chronic obstructive pulmonary disease	0.000562	0.0063	CcSEcCtD
Flutamide—Decreased appetite—Roflumilast—chronic obstructive pulmonary disease	0.00056	0.00628	CcSEcCtD
Flutamide—CYP1B1—respiratory system—chronic obstructive pulmonary disease	0.00056	0.0625	CbGeAlD
Flutamide—Fatigue—Roflumilast—chronic obstructive pulmonary disease	0.000556	0.00623	CcSEcCtD
Flutamide—Constipation—Roflumilast—chronic obstructive pulmonary disease	0.000551	0.00618	CcSEcCtD
Flutamide—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.000531	0.00596	CcSEcCtD
Flutamide—Hyperglycaemia—Formoterol—chronic obstructive pulmonary disease	0.000519	0.00582	CcSEcCtD
Flutamide—Hyperglycaemia—Arformoterol—chronic obstructive pulmonary disease	0.000519	0.00582	CcSEcCtD
Flutamide—Tension—Aminophylline—chronic obstructive pulmonary disease	0.000517	0.0058	CcSEcCtD
Flutamide—Nervousness—Aminophylline—chronic obstructive pulmonary disease	0.000511	0.00574	CcSEcCtD
Flutamide—Drowsiness—Montelukast—chronic obstructive pulmonary disease	0.000502	0.00563	CcSEcCtD
Flutamide—CYP1B1—connective tissue—chronic obstructive pulmonary disease	0.000493	0.055	CbGeAlD
Flutamide—Hyperglycaemia—Salbutamol—chronic obstructive pulmonary disease	0.00049	0.00549	CcSEcCtD
Flutamide—Jaundice—Montelukast—chronic obstructive pulmonary disease	0.00049	0.00549	CcSEcCtD
Flutamide—Haematuria—Formoterol—chronic obstructive pulmonary disease	0.000489	0.00548	CcSEcCtD
Flutamide—Haematuria—Arformoterol—chronic obstructive pulmonary disease	0.000489	0.00548	CcSEcCtD
Flutamide—Drowsiness—Salbutamol—chronic obstructive pulmonary disease	0.000484	0.00543	CcSEcCtD
Flutamide—Jaundice—Salbutamol—chronic obstructive pulmonary disease	0.000472	0.00529	CcSEcCtD
Flutamide—AR—connective tissue—chronic obstructive pulmonary disease	0.000467	0.0521	CbGeAlD
Flutamide—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.000462	0.00519	CcSEcCtD
Flutamide—Haematuria—Salbutamol—chronic obstructive pulmonary disease	0.000462	0.00518	CcSEcCtD
Flutamide—Oedema peripheral—Arformoterol—chronic obstructive pulmonary disease	0.000454	0.00509	CcSEcCtD
Flutamide—Oedema peripheral—Formoterol—chronic obstructive pulmonary disease	0.000454	0.00509	CcSEcCtD
Flutamide—Hepatitis—Montelukast—chronic obstructive pulmonary disease	0.000451	0.00506	CcSEcCtD
Flutamide—CYP1B1—smooth muscle tissue—chronic obstructive pulmonary disease	0.000451	0.0503	CbGeAlD
Flutamide—Ecchymosis—Prednisolone—chronic obstructive pulmonary disease	0.000449	0.00503	CcSEcCtD
Flutamide—Anxiety—Aminophylline—chronic obstructive pulmonary disease	0.000447	0.00501	CcSEcCtD
Flutamide—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.000441	0.00495	CcSEcCtD
Flutamide—AR—bronchus—chronic obstructive pulmonary disease	0.000436	0.0487	CbGeAlD
Flutamide—Hypertension—Tiotropium—chronic obstructive pulmonary disease	0.000429	0.00481	CcSEcCtD
Flutamide—AR—smooth muscle tissue—chronic obstructive pulmonary disease	0.000427	0.0477	CbGeAlD
Flutamide—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000426	0.00478	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.00042	0.00471	CcSEcCtD
Flutamide—Diabetes mellitus—Prednisolone—chronic obstructive pulmonary disease	0.000414	0.00465	CcSEcCtD
Flutamide—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00041	0.0046	CcSEcCtD
Flutamide—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.00041	0.00459	CcSEcCtD
Flutamide—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000406	0.00456	CcSEcCtD
Flutamide—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000406	0.00455	CcSEcCtD
Flutamide—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.000405	0.00455	CcSEcCtD
Flutamide—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000404	0.00453	CcSEcCtD
Flutamide—CYP1A2—respiratory system—chronic obstructive pulmonary disease	0.000401	0.0448	CbGeAlD
Flutamide—CYP1A1—respiratory system—chronic obstructive pulmonary disease	0.000396	0.0442	CbGeAlD
Flutamide—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.000394	0.00442	CcSEcCtD
Flutamide—Tension—Formoterol—chronic obstructive pulmonary disease	0.000393	0.00441	CcSEcCtD
Flutamide—Tension—Arformoterol—chronic obstructive pulmonary disease	0.000393	0.00441	CcSEcCtD
Flutamide—Nervousness—Arformoterol—chronic obstructive pulmonary disease	0.000389	0.00437	CcSEcCtD
Flutamide—Nervousness—Formoterol—chronic obstructive pulmonary disease	0.000389	0.00437	CcSEcCtD
Flutamide—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.000389	0.00436	CcSEcCtD
Flutamide—CYP3A5—respiratory system—chronic obstructive pulmonary disease	0.000387	0.0432	CbGeAlD
Flutamide—Increased appetite—Prednisolone—chronic obstructive pulmonary disease	0.000384	0.0043	CcSEcCtD
Flutamide—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000383	0.00429	CcSEcCtD
Flutamide—Ulcer—Prednisone—chronic obstructive pulmonary disease	0.000381	0.00428	CcSEcCtD
Flutamide—Dermatitis bullous—Prednisolone—chronic obstructive pulmonary disease	0.000377	0.00423	CcSEcCtD
Flutamide—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.000374	0.00419	CcSEcCtD
Flutamide—Ill-defined disorder—Arformoterol—chronic obstructive pulmonary disease	0.000372	0.00417	CcSEcCtD
Flutamide—Ill-defined disorder—Formoterol—chronic obstructive pulmonary disease	0.000372	0.00417	CcSEcCtD
Flutamide—Tension—Salbutamol—chronic obstructive pulmonary disease	0.000371	0.00417	CcSEcCtD
Flutamide—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.000368	0.00412	CcSEcCtD
Flutamide—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.000367	0.00411	CcSEcCtD
Flutamide—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.000361	0.00405	CcSEcCtD
Flutamide—Malaise—Formoterol—chronic obstructive pulmonary disease	0.000361	0.00405	CcSEcCtD
Flutamide—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.000351	0.00394	CcSEcCtD
Flutamide—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000347	0.00389	CcSEcCtD
Flutamide—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.000346	0.00388	CcSEcCtD
Flutamide—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.000346	0.00388	CcSEcCtD
Flutamide—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.000341	0.00383	CcSEcCtD
Flutamide—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.00034	0.00381	CcSEcCtD
Flutamide—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.00034	0.00381	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000339	0.0038	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000339	0.0038	CcSEcCtD
Flutamide—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000337	0.00378	CcSEcCtD
Flutamide—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000337	0.00378	CcSEcCtD
Flutamide—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000333	0.00374	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000332	0.00372	CcSEcCtD
Flutamide—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000327	0.00367	CcSEcCtD
Flutamide—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000327	0.00367	CcSEcCtD
Flutamide—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000327	0.00366	CcSEcCtD
Flutamide—Ecchymosis—Prednisone—chronic obstructive pulmonary disease	0.000326	0.00366	CcSEcCtD
Flutamide—CYP1A1—bronchus—chronic obstructive pulmonary disease	0.000326	0.0364	CbGeAlD
Flutamide—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000321	0.0036	CcSEcCtD
Flutamide—Oedema—Montelukast—chronic obstructive pulmonary disease	0.00032	0.00359	CcSEcCtD
Flutamide—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000318	0.00357	CcSEcCtD
Flutamide—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000318	0.00356	CcSEcCtD
Flutamide—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000318	0.00356	CcSEcCtD
Flutamide—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000314	0.00352	CcSEcCtD
Flutamide—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000311	0.00349	CcSEcCtD
Flutamide—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000309	0.00346	CcSEcCtD
Flutamide—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000304	0.00341	CcSEcCtD
Flutamide—Diabetes mellitus—Prednisone—chronic obstructive pulmonary disease	0.000301	0.00338	CcSEcCtD
Flutamide—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.0003	0.00336	CcSEcCtD
Flutamide—CYP1B1—lung—chronic obstructive pulmonary disease	0.000297	0.0332	CbGeAlD
Flutamide—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000296	0.00332	CcSEcCtD
Flutamide—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000296	0.00332	CcSEcCtD
Flutamide—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000294	0.0033	CcSEcCtD
Flutamide—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000294	0.0033	CcSEcCtD
Flutamide—CYP1A1—trachea—chronic obstructive pulmonary disease	0.000292	0.0326	CbGeAlD
Flutamide—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000291	0.00326	CcSEcCtD
Flutamide—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000291	0.00326	CcSEcCtD
Flutamide—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.00029	0.00325	CcSEcCtD
Flutamide—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000287	0.00322	CcSEcCtD
Flutamide—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000285	0.00319	CcSEcCtD
Flutamide—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000284	0.00319	CcSEcCtD
Flutamide—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000282	0.00316	CcSEcCtD
Flutamide—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000282	0.00316	CcSEcCtD
Flutamide—AR—lung—chronic obstructive pulmonary disease	0.000281	0.0314	CbGeAlD
Flutamide—Constipation—Formoterol—chronic obstructive pulmonary disease	0.00028	0.00314	CcSEcCtD
Flutamide—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.00028	0.00314	CcSEcCtD
Flutamide—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000279	0.00313	CcSEcCtD
Flutamide—Increased appetite—Prednisone—chronic obstructive pulmonary disease	0.000279	0.00313	CcSEcCtD
Flutamide—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000276	0.0031	CcSEcCtD
Flutamide—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000275	0.00308	CcSEcCtD
Flutamide—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000273	0.00306	CcSEcCtD
Flutamide—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000271	0.00304	CcSEcCtD
Flutamide—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000271	0.00304	CcSEcCtD
Flutamide—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.00027	0.00302	CcSEcCtD
Flutamide—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.00027	0.00302	CcSEcCtD
Flutamide—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000269	0.00302	CcSEcCtD
Flutamide—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000268	0.00301	CcSEcCtD
Flutamide—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000268	0.00301	CcSEcCtD
Flutamide—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000266	0.00299	CcSEcCtD
Flutamide—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000264	0.00296	CcSEcCtD
Flutamide—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000258	0.00289	CcSEcCtD
Flutamide—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000256	0.00287	CcSEcCtD
Flutamide—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000255	0.00286	CcSEcCtD
Flutamide—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000255	0.00286	CcSEcCtD
Flutamide—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000255	0.00285	CcSEcCtD
Flutamide—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000254	0.00285	CcSEcCtD
Flutamide—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000241	0.0027	CcSEcCtD
Flutamide—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000235	0.00263	CcSEcCtD
Flutamide—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000235	0.00263	CcSEcCtD
Flutamide—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000231	0.0026	CcSEcCtD
Flutamide—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000231	0.0026	CcSEcCtD
Flutamide—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.00023	0.00258	CcSEcCtD
Flutamide—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000227	0.00254	CcSEcCtD
Flutamide—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000224	0.00251	CcSEcCtD
Flutamide—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000224	0.00251	CcSEcCtD
Flutamide—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000222	0.00249	CcSEcCtD
Flutamide—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000219	0.00246	CcSEcCtD
Flutamide—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000219	0.00245	CcSEcCtD
Flutamide—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000217	0.00243	CcSEcCtD
Flutamide—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000216	0.00243	CcSEcCtD
Flutamide—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000216	0.00243	CcSEcCtD
Flutamide—CYP1A2—lung—chronic obstructive pulmonary disease	0.000213	0.0238	CbGeAlD
Flutamide—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000212	0.00238	CcSEcCtD
Flutamide—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000211	0.00237	CcSEcCtD
Flutamide—CYP1A1—lung—chronic obstructive pulmonary disease	0.00021	0.0235	CbGeAlD
Flutamide—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.000208	0.00234	CcSEcCtD
Flutamide—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000208	0.00233	CcSEcCtD
Flutamide—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000208	0.00233	CcSEcCtD
Flutamide—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000206	0.00231	CcSEcCtD
Flutamide—Rash—Formoterol—chronic obstructive pulmonary disease	0.000206	0.00231	CcSEcCtD
Flutamide—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000206	0.00231	CcSEcCtD
Flutamide—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000206	0.00231	CcSEcCtD
Flutamide—CYP3A5—lung—chronic obstructive pulmonary disease	0.000205	0.0229	CbGeAlD
Flutamide—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000205	0.0023	CcSEcCtD
Flutamide—Headache—Formoterol—chronic obstructive pulmonary disease	0.000205	0.0023	CcSEcCtD
Flutamide—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000204	0.00229	CcSEcCtD
Flutamide—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.000204	0.00229	CcSEcCtD
Flutamide—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000204	0.00228	CcSEcCtD
Flutamide—Rash—Montelukast—chronic obstructive pulmonary disease	0.000202	0.00227	CcSEcCtD
Flutamide—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000202	0.00226	CcSEcCtD
Flutamide—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000201	0.00226	CcSEcCtD
Flutamide—Headache—Montelukast—chronic obstructive pulmonary disease	0.000201	0.00225	CcSEcCtD
Flutamide—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000196	0.0022	CcSEcCtD
Flutamide—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000196	0.0022	CcSEcCtD
Flutamide—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000195	0.00218	CcSEcCtD
Flutamide—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000195	0.00218	CcSEcCtD
Flutamide—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000194	0.00218	CcSEcCtD
Flutamide—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000194	0.00218	CcSEcCtD
Flutamide—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000193	0.00217	CcSEcCtD
Flutamide—Nausea—Montelukast—chronic obstructive pulmonary disease	0.00019	0.00213	CcSEcCtD
Flutamide—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000187	0.0021	CcSEcCtD
Flutamide—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000183	0.00206	CcSEcCtD
Flutamide—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000183	0.00205	CcSEcCtD
Flutamide—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000177	0.00199	CcSEcCtD
Flutamide—AHR—Adipogenesis—TNF—chronic obstructive pulmonary disease	0.000171	0.00202	CbGpPWpGaD
Flutamide—CYP1A2—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.000166	0.00196	CbGpPWpGaD
Flutamide—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000162	0.00191	CbGpPWpGaD
Flutamide—CYP3A5—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000161	0.0019	CbGpPWpGaD
Flutamide—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.00016	0.0018	CcSEcCtD
Flutamide—AHR—Integrated Breast Cancer Pathway—EGFR—chronic obstructive pulmonary disease	0.000159	0.00188	CbGpPWpGaD
Flutamide—CYP1B1—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000158	0.00187	CbGpPWpGaD
Flutamide—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000158	0.00177	CcSEcCtD
Flutamide—CYP2C19—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000157	0.00186	CbGpPWpGaD
Flutamide—CYP1B1—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000156	0.00185	CbGpPWpGaD
Flutamide—CYP1A2—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.000156	0.00184	CbGpPWpGaD
Flutamide—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000156	0.00184	CbGpPWpGaD
Flutamide—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000154	0.00182	CbGpPWpGaD
Flutamide—CYP1A1—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000152	0.0018	CbGpPWpGaD
Flutamide—CYP2C19—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000152	0.00179	CbGpPWpGaD
Flutamide—CYP1B1—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	0.000152	0.00179	CbGpPWpGaD
Flutamide—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000146	0.00164	CcSEcCtD
Flutamide—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000146	0.00164	CcSEcCtD
Flutamide—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000146	0.00164	CcSEcCtD
Flutamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000146	0.00172	CbGpPWpGaD
Flutamide—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000144	0.00171	CbGpPWpGaD
Flutamide—AR—Regulation of nuclear SMAD2/3 signaling—SERPINE1—chronic obstructive pulmonary disease	0.000143	0.00169	CbGpPWpGaD
Flutamide—CYP3A5—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000143	0.00168	CbGpPWpGaD
Flutamide—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000142	0.0016	CcSEcCtD
Flutamide—AHR—Adipogenesis—IL6—chronic obstructive pulmonary disease	0.000138	0.00163	CbGpPWpGaD
Flutamide—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000136	0.00153	CcSEcCtD
Flutamide—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000134	0.0015	CcSEcCtD
Flutamide—AHR—Integrated Breast Cancer Pathway—TP53—chronic obstructive pulmonary disease	0.000134	0.00158	CbGpPWpGaD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000133	0.0015	CcSEcCtD
Flutamide—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000133	0.00149	CcSEcCtD
Flutamide—AR—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	0.000131	0.00155	CbGpPWpGaD
Flutamide—CYP1B1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000131	0.00155	CbGpPWpGaD
Flutamide—CYP1B1—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.00013	0.00153	CbGpPWpGaD
Flutamide—CYP2C19—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000129	0.00153	CbGpPWpGaD
Flutamide—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000129	0.00144	CcSEcCtD
Flutamide—CYP1B1—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	0.000128	0.00152	CbGpPWpGaD
Flutamide—CYP1A1—PPARA activates gene expression—CTGF—chronic obstructive pulmonary disease	0.000126	0.00148	CbGpPWpGaD
Flutamide—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000125	0.0014	CcSEcCtD
Flutamide—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000125	0.00147	CbGpPWpGaD
Flutamide—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CTGF—chronic obstructive pulmonary disease	0.000123	0.00145	CbGpPWpGaD
Flutamide—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000123	0.00138	CcSEcCtD
Flutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—chronic obstructive pulmonary disease	0.000123	0.00145	CbGpPWpGaD
Flutamide—CYP1A2—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000122	0.00145	CbGpPWpGaD
Flutamide—CYP1B1—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	0.000118	0.00139	CbGpPWpGaD
Flutamide—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000117	0.00131	CcSEcCtD
Flutamide—CYP3A5—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000117	0.00138	CbGpPWpGaD
Flutamide—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000116	0.00131	CcSEcCtD
Flutamide—AR—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	0.000116	0.00137	CbGpPWpGaD
Flutamide—CYP1B1—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	0.000116	0.00136	CbGpPWpGaD
Flutamide—CYP1B1—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	0.000116	0.00136	CbGpPWpGaD
Flutamide—AR—Integrated Breast Cancer Pathway—MMP1—chronic obstructive pulmonary disease	0.000115	0.00135	CbGpPWpGaD
Flutamide—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000114	0.00135	CbGpPWpGaD
Flutamide—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000112	0.00126	CcSEcCtD
Flutamide—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000112	0.00125	CcSEcCtD
Flutamide—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000112	0.00132	CbGpPWpGaD
Flutamide—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000112	0.00125	CcSEcCtD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000111	0.00131	CbGpPWpGaD
Flutamide—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000111	0.00124	CcSEcCtD
Flutamide—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000111	0.00124	CcSEcCtD
Flutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—chronic obstructive pulmonary disease	0.000111	0.00131	CbGpPWpGaD
Flutamide—CYP2C19—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.00011	0.0013	CbGpPWpGaD
Flutamide—Constipation—Prednisone—chronic obstructive pulmonary disease	0.00011	0.00123	CcSEcCtD
Flutamide—CYP1B1—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	0.00011	0.0013	CbGpPWpGaD
Flutamide—CYP1B1—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	0.00011	0.0013	CbGpPWpGaD
Flutamide—CYP1B1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.00011	0.00129	CbGpPWpGaD
Flutamide—CYP1B1—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000108	0.00128	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	0.000108	0.00127	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—chronic obstructive pulmonary disease	0.000108	0.00127	CbGpPWpGaD
Flutamide—CYP1A2—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000108	0.00127	CbGpPWpGaD
Flutamide—AHR—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	0.000106	0.00126	CbGpPWpGaD
Flutamide—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000106	0.00119	CcSEcCtD
Flutamide—CYP1A2—Phase II conjugation—GSTT1—chronic obstructive pulmonary disease	0.000106	0.00125	CbGpPWpGaD
Flutamide—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000105	0.00118	CcSEcCtD
Flutamide—CYP1A2—Phase II conjugation—GCLC—chronic obstructive pulmonary disease	0.000105	0.00124	CbGpPWpGaD
Flutamide—CYP3A5—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000103	0.00122	CbGpPWpGaD
Flutamide—CYP3A5—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000102	0.0012	CbGpPWpGaD
Flutamide—CYP1A2—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000101	0.00119	CbGpPWpGaD
Flutamide—CYP1B1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000101	0.00119	CbGpPWpGaD
Flutamide—CYP1B1—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	9.93e-05	0.00117	CbGpPWpGaD
Flutamide—CYP1A1—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	9.73e-05	0.00115	CbGpPWpGaD
Flutamide—AHR—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	9.73e-05	0.00115	CbGpPWpGaD
Flutamide—CYP1A1—Biological oxidations—GCLC—chronic obstructive pulmonary disease	9.62e-05	0.00114	CbGpPWpGaD
Flutamide—CYP1B1—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	9.54e-05	0.00113	CbGpPWpGaD
Flutamide—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	9.45e-05	0.00112	CbGpPWpGaD
Flutamide—CYP1B1—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	9.41e-05	0.00111	CbGpPWpGaD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	9.34e-05	0.0011	CbGpPWpGaD
Flutamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	9.24e-05	0.00109	CbGpPWpGaD
Flutamide—Asthenia—Prednisone—chronic obstructive pulmonary disease	9.24e-05	0.00104	CcSEcCtD
Flutamide—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	9.12e-05	0.00108	CbGpPWpGaD
Flutamide—Pruritus—Prednisone—chronic obstructive pulmonary disease	9.11e-05	0.00102	CcSEcCtD
Flutamide—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	9.05e-05	0.00107	CbGpPWpGaD
Flutamide—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	8.81e-05	0.000988	CcSEcCtD
Flutamide—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	8.7e-05	0.00103	CbGpPWpGaD
Flutamide—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	8.59e-05	0.00101	CbGpPWpGaD
Flutamide—CYP3A5—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	8.56e-05	0.00101	CbGpPWpGaD
Flutamide—Dizziness—Prednisone—chronic obstructive pulmonary disease	8.51e-05	0.000955	CcSEcCtD
Flutamide—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—chronic obstructive pulmonary disease	8.47e-05	0.001	CbGpPWpGaD
Flutamide—CYP3A5—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	8.44e-05	0.000997	CbGpPWpGaD
Flutamide—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	8.31e-05	0.000981	CbGpPWpGaD
Flutamide—AR—Androgen receptor signaling pathway—EGFR—chronic obstructive pulmonary disease	8.22e-05	0.000971	CbGpPWpGaD
Flutamide—Vomiting—Prednisone—chronic obstructive pulmonary disease	8.18e-05	0.000918	CcSEcCtD
Flutamide—Rash—Prednisone—chronic obstructive pulmonary disease	8.12e-05	0.00091	CcSEcCtD
Flutamide—Dermatitis—Prednisone—chronic obstructive pulmonary disease	8.11e-05	0.000909	CcSEcCtD
Flutamide—CYP1A1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	8.09e-05	0.000955	CbGpPWpGaD
Flutamide—Headache—Prednisone—chronic obstructive pulmonary disease	8.06e-05	0.000904	CcSEcCtD
Flutamide—CYP1A1—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	7.98e-05	0.000942	CbGpPWpGaD
Flutamide—CYP2C19—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	7.96e-05	0.000941	CbGpPWpGaD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	7.91e-05	0.000934	CbGpPWpGaD
Flutamide—CYP2C19—Biological oxidations—GCLC—chronic obstructive pulmonary disease	7.87e-05	0.00093	CbGpPWpGaD
Flutamide—AR—Generic Transcription Pathway—CTGF—chronic obstructive pulmonary disease	7.86e-05	0.000928	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—APIP—chronic obstructive pulmonary disease	7.68e-05	0.000907	CbGpPWpGaD
Flutamide—Nausea—Prednisone—chronic obstructive pulmonary disease	7.65e-05	0.000858	CcSEcCtD
Flutamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	7.49e-05	0.000885	CbGpPWpGaD
Flutamide—CYP1A2—Phase II conjugation—GSTP1—chronic obstructive pulmonary disease	7.35e-05	0.000868	CbGpPWpGaD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	7.26e-05	0.000857	CbGpPWpGaD
Flutamide—AR—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	7.18e-05	0.000848	CbGpPWpGaD
Flutamide—CYP3A5—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	7.14e-05	0.000843	CbGpPWpGaD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	7.12e-05	0.00084	CbGpPWpGaD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	7.12e-05	0.00084	CbGpPWpGaD
Flutamide—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	7.05e-05	0.000833	CbGpPWpGaD
Flutamide—CYP3A5—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	7.04e-05	0.000832	CbGpPWpGaD
Flutamide—AR—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	6.89e-05	0.000814	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	6.84e-05	0.000808	CbGpPWpGaD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	6.78e-05	0.0008	CbGpPWpGaD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	6.78e-05	0.0008	CbGpPWpGaD
Flutamide—CYP1A2—Phase II conjugation—GSTM1—chronic obstructive pulmonary disease	6.76e-05	0.000798	CbGpPWpGaD
Flutamide—CYP1A1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	6.75e-05	0.000797	CbGpPWpGaD
Flutamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	6.72e-05	0.000793	CbGpPWpGaD
Flutamide—CYP1A1—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	6.65e-05	0.000786	CbGpPWpGaD
Flutamide—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	6.63e-05	0.000783	CbGpPWpGaD
Flutamide—CYP2C19—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	6.62e-05	0.000782	CbGpPWpGaD
Flutamide—CYP3A5—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	6.56e-05	0.000775	CbGpPWpGaD
Flutamide—CYP2C19—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	6.53e-05	0.000771	CbGpPWpGaD
Flutamide—CYP3A5—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	6.47e-05	0.000764	CbGpPWpGaD
Flutamide—CYP3A5—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	6.22e-05	0.000735	CbGpPWpGaD
Flutamide—CYP1A2—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	6.21e-05	0.000733	CbGpPWpGaD
Flutamide—CYP1A1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	6.2e-05	0.000732	CbGpPWpGaD
Flutamide—CYP3A5—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	6.13e-05	0.000725	CbGpPWpGaD
Flutamide—CYP1A2—Biological oxidations—GCLC—chronic obstructive pulmonary disease	6.13e-05	0.000725	CbGpPWpGaD
Flutamide—CYP1A1—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	6.11e-05	0.000722	CbGpPWpGaD
Flutamide—AR—Integrated Breast Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	5.99e-05	0.000707	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	5.95e-05	0.000703	CbGpPWpGaD
Flutamide—AR—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	5.83e-05	0.000689	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	5.6e-05	0.000661	CbGpPWpGaD
Flutamide—CYP2C19—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5.52e-05	0.000652	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	5.47e-05	0.000647	CbGpPWpGaD
Flutamide—CYP2C19—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.44e-05	0.000643	CbGpPWpGaD
Flutamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	5.44e-05	0.000643	CbGpPWpGaD
Flutamide—AR—Integrated Breast Cancer Pathway—EGFR—chronic obstructive pulmonary disease	5.39e-05	0.000636	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.09e-05	0.000601	CbGpPWpGaD
Flutamide—CYP2C19—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.07e-05	0.000599	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	5.04e-05	0.000596	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	5.04e-05	0.000595	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—APIP—chronic obstructive pulmonary disease	5e-05	0.000591	CbGpPWpGaD
Flutamide—CYP2C19—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	5e-05	0.000591	CbGpPWpGaD
Flutamide—AR—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	5e-05	0.00059	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	4.96e-05	0.000586	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—GC—chronic obstructive pulmonary disease	4.95e-05	0.000584	CbGpPWpGaD
Flutamide—CYP2C19—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.81e-05	0.000568	CbGpPWpGaD
Flutamide—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	4.79e-05	0.000566	CbGpPWpGaD
Flutamide—CYP2C19—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.74e-05	0.00056	CbGpPWpGaD
Flutamide—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	4.73e-05	0.000559	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—APIP—chronic obstructive pulmonary disease	4.73e-05	0.000558	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	4.63e-05	0.000547	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.6e-05	0.000543	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	4.55e-05	0.000538	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	4.54e-05	0.000536	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	4.54e-05	0.000536	CbGpPWpGaD
Flutamide—AR—Integrated Breast Cancer Pathway—TP53—chronic obstructive pulmonary disease	4.52e-05	0.000534	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	4.46e-05	0.000527	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	4.36e-05	0.000515	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	4.32e-05	0.00051	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	4.32e-05	0.00051	CbGpPWpGaD
Flutamide—CYP1A2—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.3e-05	0.000508	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	4.25e-05	0.000502	CbGpPWpGaD
Flutamide—CYP1A2—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.24e-05	0.000501	CbGpPWpGaD
Flutamide—AR—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	4.03e-05	0.000477	CbGpPWpGaD
Flutamide—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	3.98e-05	0.00047	CbGpPWpGaD
Flutamide—CYP1A2—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.95e-05	0.000467	CbGpPWpGaD
Flutamide—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	3.93e-05	0.000464	CbGpPWpGaD
Flutamide—CYP1A2—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.9e-05	0.00046	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—APIP—chronic obstructive pulmonary disease	3.87e-05	0.000457	CbGpPWpGaD
Flutamide—AR—Gene Expression—CTGF—chronic obstructive pulmonary disease	3.78e-05	0.000447	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	3.75e-05	0.000443	CbGpPWpGaD
Flutamide—CYP1A2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.75e-05	0.000443	CbGpPWpGaD
Flutamide—CYP1A2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.7e-05	0.000437	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	3.66e-05	0.000433	CbGpPWpGaD
Flutamide—AR—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	3.58e-05	0.000423	CbGpPWpGaD
Flutamide—AR—Gene Expression—HDAC2—chronic obstructive pulmonary disease	3.53e-05	0.000416	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	3.37e-05	0.000398	CbGpPWpGaD
Flutamide—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.32e-05	0.000392	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.31e-05	0.000392	CbGpPWpGaD
Flutamide—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.27e-05	0.000387	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—GC—chronic obstructive pulmonary disease	3.22e-05	0.000381	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.13e-05	0.00037	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	3.11e-05	0.000367	CbGpPWpGaD
Flutamide—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.05e-05	0.00036	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—GC—chronic obstructive pulmonary disease	3.05e-05	0.00036	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	3.01e-05	0.000356	CbGpPWpGaD
Flutamide—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.01e-05	0.000355	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3e-05	0.000354	CbGpPWpGaD
Flutamide—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.89e-05	0.000342	CbGpPWpGaD
Flutamide—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.85e-05	0.000337	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.83e-05	0.000335	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.76e-05	0.000326	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.7e-05	0.000319	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—GCLC—chronic obstructive pulmonary disease	2.67e-05	0.000316	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.56e-05	0.000303	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.54e-05	0.0003	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	2.49e-05	0.000294	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.49e-05	0.000294	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—CTGF—chronic obstructive pulmonary disease	2.44e-05	0.000288	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	2.33e-05	0.000275	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.32e-05	0.000274	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.25e-05	0.000265	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.15e-05	0.000254	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2e-05	0.000236	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	1.94e-05	0.000229	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.87e-05	0.000221	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.85e-05	0.000218	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.85e-05	0.000218	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.81e-05	0.000213	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.76e-05	0.000208	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—GCLC—chronic obstructive pulmonary disease	1.74e-05	0.000206	CbGpPWpGaD
Flutamide—AR—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	1.72e-05	0.000204	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.72e-05	0.000203	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.66e-05	0.000197	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.65e-05	0.000194	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.63e-05	0.000193	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—CTGF—chronic obstructive pulmonary disease	1.59e-05	0.000188	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.54e-05	0.000182	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.53e-05	0.000181	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.5e-05	0.000177	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.5e-05	0.000177	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.46e-05	0.000173	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.44e-05	0.00017	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.39e-05	0.000165	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.38e-05	0.000163	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.36e-05	0.000161	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	1.35e-05	0.000159	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.26e-05	0.000148	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	1.23e-05	0.000145	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.22e-05	0.000144	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.2e-05	0.000142	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.15e-05	0.000136	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.14e-05	0.000134	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.13e-05	0.000134	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.12e-05	0.000133	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—ALB—chronic obstructive pulmonary disease	1.11e-05	0.000131	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.06e-05	0.000126	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.06e-05	0.000125	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.06e-05	0.000125	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.06e-05	0.000125	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	1.05e-05	0.000124	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	9.78e-06	0.000116	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	9.57e-06	0.000113	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.44e-06	0.000112	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.31e-06	0.00011	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.68e-06	0.000102	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.22e-06	9.71e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.19e-06	9.67e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	8.1e-06	9.56e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	7.39e-06	8.73e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.36e-06	8.69e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.25e-06	8.57e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—ALB—chronic obstructive pulmonary disease	7.23e-06	8.54e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—NOS3—chronic obstructive pulmonary disease	6.92e-06	8.17e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—ALB—chronic obstructive pulmonary disease	6.83e-06	8.07e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.81e-06	8.04e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.76e-06	7.98e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—NOS3—chronic obstructive pulmonary disease	6.53e-06	7.72e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.41e-06	7.57e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.68e-06	6.71e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.6e-06	6.61e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	5.59e-06	6.6e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	5.35e-06	6.32e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.22e-06	6.16e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.95e-06	5.84e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	4.36e-06	5.15e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	4.17e-06	4.92e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	3.36e-06	3.97e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	3.22e-06	3.8e-05	CbGpPWpGaD
